https://www.pharmaceutical-technology.com/sector/therapy-area/oncology/ The leading site for news and procurement in the pharmaceutical industry Wed, 17 Apr 2024 14:35:13 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.2 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png https://www.pharmaceutical-technology.com/sector/therapy-area/oncology/ 32 32 https://www.pharmaceutical-technology.com/news/ultimovacs-downsizes-to-funnel-funds-to-cancer-vaccine-programme/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2209421681.jpg Wed, 17 Apr 2024 11:07:21 +0000 https://www.pharmaceutical-technology.com/?p=297208 https://www.pharmaceutical-technology.com/news/portage-mulls-company-closure-pauses-enrolment-for-lead-clinical-programme/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2213945251-scaled.jpg Mon, 15 Apr 2024 12:58:55 +0000 https://www.pharmaceutical-technology.com/news/portage-mulls-company-closure-pauses-enrolment-for-lead-clinical-programme/ https://www.pharmaceutical-technology.com/news/sanofi-advances-nk-cell-engager-to-phase-ii-for-blood-cancer-treatment/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2053426424.jpg Mon, 15 Apr 2024 11:07:45 +0000 https://www.pharmaceutical-technology.com/uncategorized/sanofi-advances-nk-cell-engager-to-phase-ii-for-blood-cancer-treatment/ https://www.pharmaceutical-technology.com/news/candel-wins-fda-orphan-drug-designation-for-pancreatic-cancer-drug/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_1638621190.jpg Fri, 12 Apr 2024 14:22:15 +0000 https://www.pharmaceutical-technology.com/news/candel-wins-fda-orphan-drug-designation-for-pancreatic-cancer-drug/ https://www.pharmaceutical-technology.com/news/century-secures-60m-in-stock-sale-and-buys-preclinical-cell-therapy-biotech/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2119416338-1.jpg Fri, 12 Apr 2024 13:50:52 +0000 https://www.pharmaceutical-technology.com/news/century-secures-60m-in-stock-sale-and-buys-preclinical-cell-therapy-biotech/ https://www.pharmaceutical-technology.com/news/novartis-enters-deal-arvinas/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/novartis.jpg Fri, 12 Apr 2024 08:19:38 +0000 https://www.pharmaceutical-technology.com/news/novartis-enters-deal-arvinas/ https://www.pharmaceutical-technology.com/news/ose-wins-french-govt-grant-for-phase-iii-trial-for-cancer-vaccine/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2052828674-1.jpg Thu, 11 Apr 2024 10:06:06 +0000 https://www.pharmaceutical-technology.com/?p=296456 https://www.pharmaceutical-technology.com/news/lisata-wins-fda-orphan-drug-status-for-bone-cancer-candidate/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_1176407551.jpg Wed, 10 Apr 2024 14:07:35 +0000 https://www.pharmaceutical-technology.com/news/lisata-wins-fda-orphan-drug-status-for-bone-cancer-candidate/ https://www.pharmaceutical-technology.com/news/torl-scores-158m-in-series-b2-to-advance-adc-cancer-therapies/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_1897091614-2.jpg Wed, 10 Apr 2024 13:53:43 +0000 https://www.pharmaceutical-technology.com/news/torl-scores-158m-in-series-b2-to-advance-adc-cancer-therapies/ https://www.pharmaceutical-technology.com/news/medicxi-starpharma-oncology/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_5221108783.jpg Mon, 08 Apr 2024 09:53:29 +0000 https://www.pharmaceutical-technology.com/news/medicxi-starpharma-oncology/